Alexion Pharmaceuticals, Inc.
N-acetyl-alpha-D-glucosaminidase deficiency compositions and methods

Abstract:

Compositions and methods relating to potentially pathogenic mutations in the nucleotide sequence of a human NAGLU gene. Some NAGLU gene variants have been discovered to be associated with reduced N-acetyl-.alpha.-D-glucosaminidase (NAGLU) activity.